1. Absood A, Chen D, Wang ZY, Hakanson R. Vascular effects of pituitary adenylate cyclaseactivating peptide: A comparison with vasoactive intestinal peptide. Regul Pept 1992;40:323–329.
2. Amenta F, Cavalotti C, De Michele M, De Vincentis G, Rossodivita A, Rossodivita I. Vasoactive intestinal polypeptide receptors in rat cerebral vessels: An autoradiographic study. J Auton Pharmacol 1991;11:285–293.
3. Arimura A. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol. 1998;48:301–331.
4. Anzai M, Suzuki Y, Takayasu M, Kajita Y, Mori Y, Seki Y, Saito K, Shibuya M. Vasorelaxant effect of PACAP-27 on canine cerebral arteries and rat intracerebral arterioles. Eur J Pharmacol 1995;285:173–179.
5. Ascuitto RJ, Ross-Ascuitto NT, Waddel AE, Kadowitz PJ. Contractile and coronary vascular effects of pituitary adenylate cyclase-activating polypeptide in neonatal pig hearts. Cardiovasc Res 1996;31:153–159.